Burris Jeffrey W 4
4 · Indivior Pharmaceuticals, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) CLO Jeffrey Burris Receives RSU Awards
What Happened Jeffrey W. Burris, Indivior Pharmaceuticals' Chief Legal Officer, received a total of 131,197 restricted stock units (RSUs) across two filings: 104,300 performance-based RSUs (reported as a derivative award) and 26,897 time‑based RSUs. All awards show $0 cash paid because these are stock grants, not purchases. The 104,300 performance RSUs were certified on Feb 9, 2026 and are scheduled to vest (subject to continued employment) on March 3, 2026; the 26,897 RSUs vest in three equal annual installments beginning Feb 10, 2027.
Key Details
- Transaction dates and types:
- Feb 9, 2026 — Award (derivative/performance RSUs): 104,300 RSUs; $0 cash consideration. (Performance conditions certified Feb 9, 2026; vests Mar 3, 2026 subject to continued employment.)
- Feb 10, 2026 — Award (time‑based RSUs): 26,897 RSUs; $0 cash consideration. (Vest in three equal annual installments starting Feb 10, 2027.)
- Aggregate shares granted: 131,197 RSUs.
- Reported value: $0 recorded for both grants (standard for RSU awards).
- Shares owned after transaction: not specified in the provided Form 4 filing.
- Footnotes: F1 describes the three‑year vesting schedule for the 26,897 RSUs; F2 explains the 104,300 RSUs were a conditional performance award granted Mar 3, 2023 and certified Feb 9, 2026.
- Filing timeliness: Form filed Feb 12, 2026. The Feb 10 grant appears timely; the Feb 9 certification/award was reported one business day after the two‑day Form 4 deadline.
Context RSU grants are compensatory awards and do not involve the insider spending cash to buy shares; they typically vest over time or upon performance certification. Performance RSUs (the 104,300) are derivative awards that convert into common shares upon satisfaction of performance and continued‑employment conditions. Such awards are common for executive compensation and do not by themselves indicate immediate buying or selling intent.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-10+26,897→ 27,657 total - Award
Performance Stock Units
[F2]2026-02-09+104,300→ 104,300 totalExercise: $0.00From: 2026-03-03→ Common Stock (104,300 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
- [F2]On March 3, 2023, the Reporting Person was granted a conditional award for 104,300 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026.